Drug intelligence / Profile preview

CGSPGWVRC-GG-VLRRDKYGPPT

Development stage
Preclinical
Lead developer
Fudan University
Modality
Peptides
Administration
Intravenous
01

Overview

CGSPGWVRC-GG-VLRRDKYGPPT is a lung endothelial-targeted inhibitory peptide designed to block the lactylation of serine and arginine-rich splicing factor 4 (SRSF4) at the lysine 95 (K95) site. Developed by researchers at Fudan University and Zhongshan Hospital, the peptide consists of a lung-homing motif (CGSPGWVRC) linked via a gly-gly (GG) spacer to an inhibitory sequence targeting SRSF4 K95 lactylation. In preclinical models of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), the peptide prevents SRSF4 K95 lactylation, thereby suppressing the alternative splicing of acid sphingomyelinase (encoded by SMPD1) to the active ASM-1 isoform. This inhibition reduces ceramide production, attenuates vascular barrier dysfunction, and mitigates pulmonary inflammation and vascular permeability.

Other names
CGSPGWVRC-GG-VLRRDKYGPPT
02

Targets

SMPD1 (Acid sphingomyelinase)SRSF4 (Serine/arginine-rich splicing factor 4)

Beyond the preview

Go deeper on CGSPGWVRC-GG-VLRRDKYGPPT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CGSPGWVRC-GG-VLRRDKYGPPT.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call